pressat6d
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
The Phase III trial AV001 aims to evaluate QUTENZA ® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...
ots6d
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neur
The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after ...
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA
The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...
MarketWatch4d
Foot Locker Inc.
Under Armour Inc. Cl C-11.87% $4.56B Under Armour Inc. Cl A-13.03% $4.56B ...
lewishamandgreenwich.nhs.uk3d
Foot health
However, only people with a health condition that impacts on the health of their feet, or people with a significant foot problem such as a wound, acutely ingrowing nail or painful musculoskeletal ...